Skip to main content
. 2022 Feb 4;47(8):1523–1536. doi: 10.1038/s41386-022-01278-5

Fig. 2. The synthesized standardized mean difference (SMD) of 10 comparative datasets.

Fig. 2

The pooled SMD in healthy subjects showed that exogenous melatonin significantly decreased SOL compared to placebo. Administration of exogenous melatonin at 18:00 and 20:00 significantly decreased SOL (A). Low dosages significantly shortened SOL (B). BT bedtime, SD standard deviation.